European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

Obiettivo

The PREFER project will deliver an overview and evaluation of preference elicitation methods to be applied in the entire drug life cycle, i.e. in the early stages of identifying medical needs, in clinical testing, to guide decisions on reimbursement and to make decisions on withdrawal of drugs from the market. A broad array of (combinations of) patient preference methods will be tested prospectively in a large number of case studies. The availability of large patient cohorts will enable to test new methods or deviations from existing methods in a randomized manner, by comparing well-known methods with newer ones. The use of simulation studies will both contribute to smarter design of case studies and to exploring the sensitivity of outcomes of preference studies. Based on discussions with a broad representation of stakeholders e.g. patients, patient organisations, regulatory authorities, HTA bodies and reimbursement agencies, suitable methods will be tested and their contributions to improved decision making will be discussed in recommendations adapted to the needs of all relevant stakeholders. The recommendations from PREFER are expected to lead to changed practices, in that industry will routinely assess whether a preference study would add value at key decision points in the medicinal product life cycle and, if so, implement patient-preference elicitation studies according to the PREFER project recommendations. The PREFER consortium consist of 16 industry partners and 16 academic and SME members including representation from academia, patient organizations, HTA bodies, reimbursement agencies, and project management.

Campo scientifico

Programma(i)

Argomento(i)

Invito a presentare proposte

H2020-JTI-IMI2-2015-05-two-stage

Vedi altri progetti per questo bando

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

UPPSALA UNIVERSITET
Contribution nette de l'UE
€ 1 455 666,95
Indirizzo
VON KRAEMERS ALLE 4
751 05 Uppsala
Svezia

Mostra sulla mappa
Regione
Östra Sverige Östra Mellansverige Uppsala län
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 455 666,95

Partecipanti (35)

Condividi questa pagina

Scarica

Ultimo aggiornamento: 16 Dicembre 2022

Il mio booklet

Permalink: https://cordis.europa.eu/project/id/115966/it

European Union, 2024